<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>Bioliberty blog</title>
    <link>https://www.bioliberty.com/news</link>
    <description>Discover the latest from Bioliberty as we develop rehabilitation technology that supports clinicians and helps more people work toward greater independence.</description>
    <language>en</language>
    <pubDate>Tue, 17 Nov 2026 11:47:35 GMT</pubDate>
    <dc:date>2026-11-17T11:47:35Z</dc:date>
    <dc:language>en</dc:language>
    <item>
      <title>Investment to extend the reach of rehabilitation technology</title>
      <link>https://www.bioliberty.com/news/investment-to-extend-the-reach-of-rehabilitation-technology</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://www.bioliberty.com/news/investment-to-extend-the-reach-of-rehabilitation-technology" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.bioliberty.com/hubfs/Blog%20featured%20images-3.jpg" alt="Investment and board member updates from Bioliberty" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;p style="line-height: 1.15;"&gt;Over the past 18 months, Bioliberty has progressed from launching our first product to&lt;span style="font-weight: normal;"&gt;introducing it across 26 inpatient rehabilitation facilities in the United States&lt;/span&gt;. With new investment, experienced Board leadership, and growing insight from real-world clinical use, we are now ready to take the next step: extending the reach of rehabilitation technology across care settings and, in the future, into the home.&lt;/p&gt;</description>
      <content:encoded>&lt;p style="line-height: 1.15;"&gt;Over the past 18 months, Bioliberty has progressed from launching our first product to&lt;span&gt; &lt;/span&gt;&lt;span style="font-weight: normal;"&gt;introducing it across 26 inpatient rehabilitation facilities in the United States&lt;/span&gt;. With new investment, experienced Board leadership, and growing insight from real-world clinical use, we are now ready to take the next step: extending the reach of rehabilitation technology across care settings and, in the future, into the home.&lt;/p&gt; 
&lt;h1 style="line-height: 1.15;"&gt;Bioliberty investment news and Board appointments&lt;/h1&gt; 
&lt;p style="line-height: 1.15;"&gt;&lt;br&gt;In March 2026, &lt;a href="https://www.globenewswire.com/news-release/2026/03/19/3258693/0/en/bioliberty-raises-10-2-million-to-build-functional-intelligence-capabilities-for-post-acute-care.html" style="font-size: 1rem; font-weight: bold;"&gt;we announced an $8.2 million Series A investment&lt;/a&gt;, including a $4 million&amp;nbsp; investment from the Scottish National Investment Bank. &lt;span style="font-size: 1rem;"&gt;E&lt;/span&gt;&lt;span style="font-size: 1rem;"&gt;x&lt;/span&gt;&lt;span style="font-size: 1rem;"&gt;isting investors Archangels, Eos Advisory, Old College Capital, and Hanna Capital SEZC participated alongside new investor Conduit Connect. The investment followed a $2 million pre-Series A round raised from our existing investors in mid-2025.&lt;/span&gt;&lt;/p&gt; 
&lt;div style="line-height: 1.15;"&gt; 
 &lt;p&gt;In November 2026, the Series A raise was named&lt;span&gt; &lt;/span&gt;&lt;span style="font-weight: normal;"&gt;Deal of the Year (Sub £10m)&lt;/span&gt;&lt;span&gt; &lt;/span&gt;at the &lt;a href="https://www.insidermedia.com/news/scotland/scotlands-dealmakers-showcased-at-significant-awards" style="font-weight: bold;"&gt;Insider Media Scotland Dealmakers Awards&lt;/a&gt;, recognizing the strength of the investment and the opportunity ahead for Bioliberty.&lt;/p&gt; 
 &lt;p&gt;As part of the financing, we were delighted to welcome two leaders with extensive experience across rehabilitation, post-acute care, and U.S. healthcare policy to our Board of Directors:&lt;/p&gt; 
 &lt;ul&gt; 
  &lt;li&gt;Russell Bailey, PT, FACHE, President of Lifepoint Rehabilitation&lt;/li&gt; 
  &lt;li&gt;Dana Prommel Strauss, DPT, Lead Director, Public Policy and Government Affairs, CVS Health&lt;/li&gt; 
 &lt;/ul&gt; 
 &lt;p&gt;Together, Russell and Dana bring valuable clinical, operational, and policy perspectives that will help guide Bioliberty as we expand across U.S. healthcare settings and work toward extending rehabilitation into the home.&lt;/p&gt; 
 &lt;p&gt;Russell has dedicated more than 30 years to rehabilitation and healthcare operations. As President of Lifepoint Rehabilitation, he oversees more than 300 hospital-based rehabilitation programs, joint ventures, and standalone rehabilitation hospitals. He has also served on the Board of the American Medical Rehabilitation Providers Association for more than nine years. His experience scaling rehabilitation services while maintaining consistent, high-quality care will be particularly valuable as Bioliberty supports a growing network of providers.&lt;/p&gt; 
 &lt;p&gt;Dana is a Doctor of Physical Therapy with nearly 20 years of experience spanning clinical practice, population health, and healthcare policy. In her current role at CVS Health, she focuses on policy affecting healthcare delivery, including value-based care, Medicare, post-acute care, and home-based care. Her understanding of how care is evolving across settings will help inform our work to create a more connected rehabilitation journey, from professional care to the home.&lt;/p&gt; 
 &lt;p&gt;In October,&lt;span&gt; &lt;/span&gt;&lt;a href="https://nrtimes.co.uk/bioliberty-raises-e2-95m-to-bring-rehabilitation-technology-into-the-home-kind26/" style="font-weight: bold;"&gt;we closed a further $3.3 million Series A extension&lt;/a&gt;, welcoming four new investors: U.S.-based TGH Ventures, Ballad Ventures, and 25M Health, and Northern Ireland-based Whiterock.&lt;/p&gt; 
 &lt;div style="line-height: 1.15;"&gt;
  This investment will support the continued development of the Bioliberty platform, U.S. market expansion, and our home solution, while advancing AI capabilities 
  &lt;span&gt;to further augment therapy and assessment for physical and occupational therapists.&lt;/span&gt;
 &lt;/div&gt; 
 &lt;div style="line-height: 20px;"&gt;
  &amp;nbsp;
 &lt;/div&gt; 
 &lt;div style="line-height: 1.15;"&gt;
  Ultimately, expanding the reach of the our&amp;nbsp;platform will help address an important challenge in rehabilitation: enabling people to continue working toward their goals as they move between care settings.
  &lt;br&gt;
  &lt;br&gt;
 &lt;/div&gt; 
&lt;/div&gt; 
&lt;div style="line-height: 1.15;"&gt; 
 &lt;p style="line-height: 1.15; font-size: 10px;"&gt;&lt;img src="https://www.bioliberty.com/hs-fs/hubfs/_U5A1097-Enhanced-NR.jpg?width=5831&amp;amp;height=3111&amp;amp;name=_U5A1097-Enhanced-NR.jpg" width="5831" height="3111" alt="The Bioliberty leadership team 2026" style="height: auto; max-width: 100%; width: 5831px; margin-left: auto; margin-right: auto; display: block;"&gt;&lt;span style="font-size: 14px;"&gt;From left to right, Russell Bailey (Board Member), Ross O'Hanlon (Co-founder and CTO), Albert Nicholl, (Chairman), Dana Prommel Strauss (Board Member), Rowan Armstrong (Co-founder and CEO), David O'Reilly (Board Member), Conan Bradley (Co-founder and CCO), Shéa Quinn (Co-founder and COO) and Barry Hextall (CFO.)&lt;/span&gt;&lt;/p&gt; 
 &lt;h1&gt;Why continued rehabilitation matters&lt;/h1&gt; 
 &lt;div style="line-height: 20px;"&gt;
  &amp;nbsp;
 &lt;/div&gt; 
 &lt;div style="line-height: 20px;"&gt; 
  &lt;div style="line-height: 20px;"&gt; 
   &lt;div style="line-height: 1.15;"&gt;
    &lt;span style="font-size: 1rem;"&gt;Stroke recovery is rarely confined to a single care setting.&lt;br&gt;&lt;br&gt;&lt;/span&gt;
   &lt;/div&gt; 
   &lt;div style="line-height: 20px;"&gt; 
    &lt;div style="line-height: 20px;"&gt; 
     &lt;p style="line-height: 1.15;"&gt;The American Heart Association and American Stroke Association’s&lt;span style="font-weight: bold;"&gt; &lt;/span&gt;&lt;a href="https://www.ahajournals.org/doi/10.1161/STR.0000000000000536" style="font-weight: bold;"&gt;2026 Guideline for Adult Stroke Rehabilitation and Recovery&lt;/a&gt; describes rehabilitation as a continuing process that can extend across inpatient, outpatient, community, and home environments.&lt;/p&gt; 
     &lt;p style="line-height: 1.15;"&gt;An acute hospital stay in the United States may last approximately four to six days, followed in some cases by 10 to 14 days of inpatient rehabilitation. Recovery of walking and upper-extremity function, however, can continue for two to six months after a stroke.&lt;/p&gt; 
     &lt;p style="line-height: 1.15;"&gt;For people who continue to have rehabilitation goals after discharge, the guideline recommends organized follow-up in outpatient, community, or home settings. Evidence reviewed in the guideline suggests that structured home-based rehabilitation can achieve outcomes comparable to hospital- or clinic-based services across areas including motor recovery, upper-extremity dexterity, balance, walking, and daily activities.&lt;/p&gt; 
     &lt;p style="line-height: 1.15;"&gt;These findings underline the importance of maintaining access to rehabilitation as people move between care settings. Discharge can represent meaningful progress, but it does not necessarily mean that a person’s recovery goals have been reached.&lt;/p&gt; 
     &lt;p style="line-height: 1.15;"&gt;Creating greater continuity between professional care and rehabilitation at home could give more people the opportunity to keep practicing meaningful movements and working toward greater independence. At Bioliberty, we are working to help bridge that gap.&lt;/p&gt; 
     &lt;p style="line-height: 1.15;"&gt;Our starting point has been the professional rehabilitation setting, where close collaboration with clinicians and patients has helped us understand how technology can support repeated movement within everyday care.&lt;/p&gt; 
    &lt;/div&gt; 
   &lt;/div&gt; 
   &lt;div style="line-height: 20px;"&gt; 
    &lt;div style="line-height: 20px;"&gt; 
     &lt;h1&gt;From launch to growing experience in clinical settings&amp;nbsp;&lt;/h1&gt; 
     &lt;div style="line-height: 20px;"&gt;
      &amp;nbsp;
     &lt;/div&gt; 
     &lt;div style="line-height: 1.15;"&gt; 
      &lt;div style="line-height: 20px;"&gt; 
       &lt;div style="line-height: 20px;"&gt; 
        &lt;p style="line-height: 1.15;"&gt;&lt;a href="https://attoday.co.uk/portable-modular-solution-aims-to-transform-therapy-through-soft-robotics-and-gamified-exercises/" style="font-weight: bold;"&gt;Bioliberty commercialized its product (formerly known as Lifehub Clinic) in May 2025&lt;/a&gt;, following close collaboration and co-development with rehabilitation professionals to understand how technology could support patients and fit naturally into clinical workflows.&lt;/p&gt; 
        &lt;p style="line-height: 1.15;"&gt;Since then, the &lt;a href="https://www.bioliberty.com/technology"&gt;Bioliberty platform&lt;/a&gt; has been introduced across 26 inpatient rehabilitation facilities in the United States and has supported 1,465 patients in their rehabilitation.&lt;/p&gt; 
        &lt;p&gt;&lt;a href="https://cr.m365copilotapp.svc.cloud.microsoft/technology" style="font-weight: bold;"&gt;The platform&lt;/a&gt;&lt;span style="font-weight: bold;"&gt; &lt;/span&gt;brings together three connected components:&lt;/p&gt; 
        &lt;ul&gt; 
         &lt;li&gt;Lifeglov, a soft-robotic glove that supports hand opening, with the level of assistance calibrated to each person&lt;/li&gt; 
         &lt;li&gt;Lifehub, which powers Lifeglov and provides an interface for engaging, therapy-based games&lt;/li&gt; 
         &lt;li&gt;Lifemind, a web-based clinician interface that centralizes therapy data captured through Lifehub&lt;/li&gt; 
        &lt;/ul&gt; 
        &lt;p style="line-height: 1.15;"&gt;Together, these components help occupational and physical therapy teams deliver repetitive hand movement practice. Lifeglov provides configurable assistance based on each person’s needs, while Lifemind automatically captures therapy activity that can help inform patient progress documentation.&lt;/p&gt; 
        &lt;p style="line-height: 1.15;"&gt;In some sessions, patients have completed&lt;span&gt; &lt;/span&gt;&lt;span style="font-weight: normal;"&gt;more than 1,000 repetitions in just 30 minutes&lt;/span&gt;&lt;span&gt; &lt;/span&gt;using Bioliberty’s technology. This demonstrates the potential for robotics to help people access the high volume of repeated movement that rehabilitation requires, while supporting clinicians to use their time and expertise effectively.&lt;/p&gt; 
        &lt;p style="line-height: 1.15;"&gt;The value does not come from technology alone. It comes from designing technology around the people delivering and receiving rehabilitation, giving patients more opportunities to practice meaningful movement and clinicians greater visibility into the therapy delivered.&lt;/p&gt; 
        &lt;p style="line-height: 1.15;"&gt;What we have learned from clinical use is now shaping the next stage of our development. Our aim is to build on the support available in professional settings and create greater continuity as people move into the next phase of their rehabilitation.&lt;/p&gt; 
       &lt;/div&gt; 
       &lt;h1 style="line-height: 1.15;"&gt;Extending rehabilitation across the continuum&lt;/h1&gt; 
       &lt;div style="line-height: 20px;"&gt; 
        &lt;div style="line-height: 20px;"&gt; 
         &lt;div style="line-height: 20px;"&gt; 
          &lt;p style="line-height: 1.15;"&gt;Our next phase of growth will extend the reach of Bioliberty’s professional technology beyond inpatient rehabilitation facilities and into acute and outpatient rehabilitation settings. Reaching people at different stages of recovery is an important step toward supporting greater continuity as rehabilitation needs and care environments change.&lt;/p&gt; 
          &lt;p style="line-height: 1.15;"&gt;Bioliberty is also developing a home solution designed for individual use outside a professional rehabilitation facility. It will form part of the same overarching Bioliberty platform as our professional solution, creating the foundation for a more connected rehabilitation experience and, over time, a more continuous view of rehabilitation data across care settings.&lt;/p&gt; 
         &lt;/div&gt; 
         &lt;div style="line-height: 1.15;"&gt;
          With new investment, experienced leadership, and insight from 1,465 patient journeys so far, we are excited to support more stages of rehabilitation. We look forward to sharing more soon.
         &lt;/div&gt; 
        &lt;/div&gt; 
       &lt;/div&gt; 
      &lt;/div&gt; 
     &lt;/div&gt; 
    &lt;/div&gt; 
   &lt;/div&gt; 
  &lt;/div&gt; 
 &lt;/div&gt; 
&lt;/div&gt; 
&lt;div style="line-height: 20px;"&gt; 
 &lt;div style="line-height: 1.15;"&gt;
  &amp;nbsp;
 &lt;/div&gt; 
&lt;/div&gt;  
&lt;img src="https://track-eu1.hubspot.com/__ptq.gif?a=148782626&amp;amp;k=14&amp;amp;r=https%3A%2F%2Fwww.bioliberty.com%2Fnews%2Finvestment-to-extend-the-reach-of-rehabilitation-technology&amp;amp;bu=https%253A%252F%252Fwww.bioliberty.com%252Fnews&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>Blog</category>
      <pubDate>Tue, 17 Nov 2026 11:34:59 GMT</pubDate>
      <guid>https://www.bioliberty.com/news/investment-to-extend-the-reach-of-rehabilitation-technology</guid>
      <dc:date>2026-11-17T11:34:59Z</dc:date>
      <dc:creator>Bioliberty</dc:creator>
    </item>
  </channel>
</rss>
